Chuck Sholtz
Vice President, Intellectual Property @ Nutcracker Therapeutics
bipj4.y44w20@6667wg904dv.2dd
Sign up to see email
Known information
- Earned B.S. and B.S.E. degrees from the University of Michigan
- Obtained an M.A. degree from Yale University
- Completed a Ph.D. in Neuroscience from Stanford University
- Holds a J.D. from Santa Clara University School of Law
- Previously served as a Director at Genentech, leading a team of IP agents/attorneys
- Worked as Vice President, Intellectual Property at Coherus Biosciences
- Spent 8 years as an IP attorney at Amgen, including as Neuroscience Therapeutic Area IP Team Lead
About Nutcracker Therapeutics
Nutcracker Therapeutics is a biotechnology company focused on developing RNA-based treatments using a proprietary platform that combines advanced engineering with high-precision biosynthesis and microfluidic technology.